Local business? Support local news on PlanoWeekly.news

Back to Texas

Texas Secures $7.5 Million Settlement with Tris Pharma Over Pediatric ADHD Drug Marketing

State prosecutors finalized a resolution concluding allegations that the pharmaceutical manufacturer misled Medicaid providers regarding how quickly an ADHD medication acted for pediatric patients.

Demarcus Ferris· AI-assisted, edited by Jake Team

October 2, 20261 min read

Pediatric healthcare settlement - illustration, Jake Team LLC

Plano, Texas — State legal authorities concluded a $7.5 million financial resolution with Tris Pharmaceuticals, resolving allegations that the drugmaker defrauded the Texas Medicaid program by misrepresenting how quickly and effectively an attention-deficit medication worked for children.

The agreement concludes litigation initiated by state prosecutors in 2023 against the pharmaceutical manufacturer and corporate executive Ketan Mehta. State investigators alleged that the company orchestrated a deceptive promotional campaign concerning Dyanavel XR, an attention-deficit/hyperactivity disorder medication marketed for pediatric patients.

According to state enforcement filings, company sales representatives conducted thousands of promotional presentations to medical practitioners, including healthcare professionals enrolled in the state Medicaid network. Regulators asserted that sales representatives made unverified representations claiming the medication took effect far more rapidly than alternative therapies while providing additional clinical advantages that lacked scientific substantiation.

"Tris Pharma is now paying millions of dollars for misleading folks about ADHD drugs being prescribed to children." — Texas Attorney General Ken Paxton

Under the terms of the finalized agreement, the pharmaceutical manufacturer agreed to transfer $7.5 million to the state treasury to resolve the statutory claims, ending the enforcement action without further trial proceedings.

In Plano, a major commercial and medical center in Collin County home to extensive pediatric practices, the state settlement directly intersects with healthcare provider compliance and clinical standards.

Sources: Office of the Texas Attorney General (October 2026): https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-secures-75-million-settlement-tris-pharma-misrepresenting-efficacy-adhd-drug

Share

Demarcus Ferris· AI-assisted, edited by Jake Team

Demarcus Ferris writes about community life, schools, public safety, and local events in Plano.

Related Stories

More in Sport

Sport

Green Bay Falls 89-57 to Texas in Kress Center Defeat

The Green Bay Phoenix suffered a lopsided 89-57 loss to visiting Texas Longhorns at the Kress Center on Wednesday. Jayda Clark led Texas with 23 points as the Longhorns improved to 5-0.

Una VargasNovember 19, 20262 min read
Sport

Washington Made Every Dallas Touch Carry More Weight

P.J. Washington’s three first-quarter threes came from three different Dallas passers, and his 21-point night included three blocks and no turnovers. The Mavericks should keep asking for that complete supporting role without treating 5-of-7 shooting as a forecast.

Una VargasNovember 19, 20263 min read
Sport

Rutgers Falls 85-73 to Houston in Las Vegas Showdown

The Scarlet Knights dropped their first game of the season, falling 85-73 to the Cougars at Michelob ULTRA Arena. Lino Mark led Rutgers with 22 points, but Houston's balanced attack proved too much to overcome.

Una VargasNovember 18, 20262 min read